FDA sends small biotech and its re­for­mu­lat­ed pain med pack­ing, trig­ger­ing a col­lapse in the share price

A small-cap biotech found­ed by Fortress has run in­to a brick wall at the FDA.

Av­enue Ther­a­peu­tics $ATXI says the agency has hit it with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.